Development of a protocol for predicting bacterial resistance to microbicides

Applied and Environmental Microbiology

Volumn 81, Issue 8, 2015, Pages 2652-2659

  Knapp, Laura ^a   Amézquita, Alejandro ^b   McClure, Peter ^b   Stewart, Sara ^b   Maillard, Jean Yves ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNILEVER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BACTERIA; CATIONIC SURFACTANTS; CHLORINE COMPOUNDS; COSMETICS; FORECASTING; SALMONELLA;

ANTIBIOTIC SUSCEPTIBILITIES; CHLORHEXIDINE DIGLUCONATE; HIGH-THROUGHPUT TECHNIQUE; KLEBSIELLA PNEUMONIAE; MICROBICIDAL FORMULATIONS; MINIMUM BACTERICIDAL CONCENTRATION (MBC); PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM;

RISK ASSESSMENT;

ANTIBIOTIC RESISTANCE; BACTERIUM; BASELINE CONDITIONS; BIOMARKER; CHEMICAL CONTROL; MODEL VALIDATION; PREDICTION; RISK FACTOR;

EUROPE; UNITED STATES;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CEPACIA; KLEBSIELLA PNEUMONIAE; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

ANTIINFECTIVE AGENT; BENZALKONIUM; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; COSMETIC;

ANALOGS AND DERIVATIVES; BACTERIUM; BURKHOLDERIA CEPACIA; DRUG EFFECTS; ENTEROBACTERIACEAE; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; PROCEDURES; PSEUDOMONAS AERUGINOSA; VALIDATION STUDY;

ANTI-BACTERIAL AGENTS; BACTERIA; BENZALKONIUM COMPOUNDS; BURKHOLDERIA CEPACIA; CHLORHEXIDINE; COSMETICS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROBACTERIACEAE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA;

EID: 84927792256     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03843-14     Document Type: Article

References (25)

1. Maillard J-Y, Bloomfield S, Coelho JR, Collier P, Cookson B, Fanning S, Hill A, Hartemann P, McBain AJ, Oggioni M, Sattar S, Schweizer HP, Threlfall J. 2013. Does microbicide use in consumer products promote antimicrobial resistance? A critical review and recommendations for a cohesive approach to risk assessment. Microb Drug Resist 19:344-354. http://dx.doi.org/10.1089/mdr.2013.0039.
2. Scientific Committee on Emerging and Newly Identified Health Risks. 2010. Research strategy to address the knowledge gaps on the antimicrobial resistance effects of biocides. European Commission, Brussels, Belgium. http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_028.pdf.
3. European Union. 27 June 2012. Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products. Off J Eur Union L 167:1-123. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2012:167:0001:0123:EN:PDF.
4. Knapp L, Rushton L, Stapleton H, Sass A, Stewart S, Amezquita A, McClure P, Mahenthiralingam E, Maillard J-Y. 2013. The effect of cationic microbicide exposure against Burkholderia cepacia complex (Bcc); the use of Burkholderia lata strain 383 as a model bacterium. J Appl Microbiol 115:1117-1126. http://dx.doi.org/10.1111/jam.12320.
5. Christensen EG, Gram L, Kastbjerg VG. 2011. Sublethal triclosan exposure decreases susceptibility to gentamicin and other aminoglycosides in Listeria monocytogenes. Antimicrob Agents Chemother 55:4064-4071. http://dx.doi.org/10.1128/AAC.00460-11.
6. Escalada MG, Harwood JL, Maillard J-Y, Ochs D. 2005. Triclosan inhibition of fatty acid synthesis and its effect on growth of Escherichia coli and Pseudomonas aeruginosa. J Antimicrob Chemother 55:879-882. http://dx.doi.org/10.1093/jac/dki123.
7. Mavri A, Smole MS. 2013. Development of antimicrobial resistance in Campylobacter jejuni and Campylobacter coli adapted to biocides. Int J Food Microbiol 160:304-312. http://dx.doi.org/10.1016/j.ijfoodmicro.2012.11.006.
8. Thomas L, Maillard J-Y, Lambert RJ, Russell AD. 2000. Development of resistance to chlorhexidine diacetate in Pseudomonas aeruginosa and the effect of a "residual" concentration. J Hosp Infect 46:297-303. http://dx.doi.org/10.1053/jhin.2000.0851.
9. Federal Register. 2013. Safety and effectiveness of consumer antiseptics; topical antimicrobial drug products for over-the-counter human use; proposed amendment of the tentative final monograph; reopening of administrative record; proposed rule. Fed Regist 78:76444-76478. http://www.gpo.gov/fdsys/pkg/FR-2013-12-17/pdf/2013-29814.pdf.
10. British Standards Institution. 31 May 2010. BS EN 1276:2009. Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of bactericidal activity of chemical disinfectants and antiseptics used in food, industrial, domestic and institutional areas. Test method and requirements (phase 2, step 1). 20-9-2009. BSI, London, United Kingdom.
11. International Organisation for Standardisation. 29 December 2006. BS EN ISO 20776-1:2006. Clinical laboratory testing and in vitro diagnostic test systems. Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. Part 1. Reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases. BSI, London, United Kingdom.
12. Andrews JM. 2009. BSAC standardized disc susceptibility testing method (version 8). J Antimicrob Chemother 64:454-489. http://dx.doi.org/10.1093/jac/dkp244.
13. Schuurmans JM, Nuri Hayali AS, Koenders BB, ter Kuile BH. 2009. Variations in MIC value caused by differences in experimental protocol. J Microbiol Methods 79:44-47. http://dx.doi.org/10.1016/j.mimet.2009.07.017.
14. Larsen GY, Stull TL, Burns JL. 1993. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis. J Clin Microbiol 31:788-792.
15. Harbarth S, Tuan SS, Horner C, Wilcox MH. 2014. Is reduced susceptibility to disinfectants and antiseptics a risk in healthcare settings? A point/counterpoint review. J Hosp Infect 87:194-202. http://dx.doi.org/10.1016/j.jhin.2014.04.012.
16. Aiello AE, Marshall B, Levy SB, Della-Latta P, Larson E. 2004. Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community. Antimicrob Agents Chemother 48:2973-2979. http://dx.doi.org/10.1128/AAC.48.8.2973-2979.2004.
17. Aiello AE, Marshall B, Levy SB, Della-Latta P, Lin SX, Larson E. 2005. Antibacterial cleaning products and drug resistance. Emerg Infect Dis 11: 1565-1570. http://dx.doi.org/10.3201/eid1110.041276.
18. Cole EC, Addison RM, Rubino JR, Leese KE, Dulaney PD, Newell MS, Wilkins J, Gaber DJ, Wineinger T, Criger DA. 2003. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers. J Appl Microbiol 95: 664-676. http://dx.doi.org/10.1046/j.1365-2672.2003.02022.x.
19. Cole EC, Addison RM, Dulaney PD, Leese KE, Madanat HM, Guffey AM. 2011. Investigation of antibiotic and antibacterial susceptibility and resistance in Staphylococcus from the skin of users and non-users of antibacterial wash products in home environments. Int J Microbiol Res 3:90-96. http://dx.doi.org/10.9735/0975-5276.3.2.90-96.
20. Bailey AM, Constantinidou C, Ivens A, Garvey MI, Webber MA, Coldham N, Hobman JL, Wain J, Woodward MJ, Piddock LJ. 2009. Exposure of Escherichia coli and Salmonella enterica serovar Typhimurium to triclosan induces a species-specific response, including drug detoxification. J Antimicrob Chemother 64:973-985. http://dx.doi.org/10.1093/jac/dkp320.
21. Furi L, Ciusa ML, Knight D, Di Lorenzo V, Tocci N, Cirasola D, Aragones L, Coelho JR, Freitas AT, Marchi E, Moce L, Visa P, Northwood JB, Viti C, Borghi E, Orefici G, Morrissey I, Oggioni MR. 2013. Evaluation of reduced susceptibility to quaternary ammonium compounds and bisbiguanides in clinical isolates and laboratory-generated mutants of Staphylococcus aureus. Antimicrob Agents Chemother 57: 3488-3497. http://dx.doi.org/10.1128/AAC.00498-13.
22. Yu BJ, Kim JA, Ju HM, Choi SK, Hwang SJ, Park S, Kim E, Pan JG. 2012. Genome-wide enrichment screening reveals multiple targets and resistance genes for triclosan in Escherichia coli. J Microbiol 50:785-791. http://dx.doi.org/10.1007/s12275-012-2439-0.
23. Scientific Committee on Emerging and Newly Identified Health Risks. 2012. Memorandum on the use of scientific literature for human health risk assessment purposes-weighing of evidence and expression of uncertainty. European Commission, Brussels, Belgium. http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_s_001.pdf.
24. Scientific Committee for Emerging and Newly Identified Health Risks. 2014. Nanosilver: safety, health and environmental effects and role in antimicrobial resistance. European Commission, Directorate General for Health and Consumers, Luxembourg. http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_039.pdf.
25. Poole K. 2001. Overcoming antimicrobial resistance by targeting resistance mechanisms. J Pharm Pharmacol 53:283-294. http://dx.doi.org/10.1211/0022357011775514.